These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 16338084)
1. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Theodore S; Cass WA; Maragos WF Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084 [TBL] [Abstract][Full Text] [Related]
2. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum. Theodore S; Cass WA; Maragos WF Exp Neurol; 2006 Jun; 199(2):490-8. PubMed ID: 16510141 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Theodore S; Cass WA; Nath A; Steiner J; Young K; Maragos WF Neurobiol Dis; 2006 Sep; 23(3):663-8. PubMed ID: 16828290 [TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus-1 protein tat and methamphetamine interactions. Theodore S; Stolberg S; Cass WA; Maragos WF Ann N Y Acad Sci; 2006 Aug; 1074():178-90. PubMed ID: 17105916 [TBL] [Abstract][Full Text] [Related]
5. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683 [TBL] [Abstract][Full Text] [Related]
6. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain. Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368 [TBL] [Abstract][Full Text] [Related]
9. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504 [TBL] [Abstract][Full Text] [Related]
10. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen. Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116 [TBL] [Abstract][Full Text] [Related]
11. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Muñoz A; Rey P; Guerra MJ; Mendez-Alvarez E; Soto-Otero R; Labandeira-Garcia JL Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218 [TBL] [Abstract][Full Text] [Related]
12. Sprouting of dopaminergic axons after striatal injury: confirmation by markers not dependent on dopamine metabolism. Liberatore GT; Finkelstein DI; Wong JY; Horne MK; Porritt MJ; Donnan GA; Howells DW Exp Neurol; 1999 Oct; 159(2):565-73. PubMed ID: 10506529 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity. Liu B; Traini R; Killinger B; Schneider B; Moszczynska A Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192 [TBL] [Abstract][Full Text] [Related]
14. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats. Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250 [TBL] [Abstract][Full Text] [Related]
15. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers. Killinger BA; Moszczynska A J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779 [TBL] [Abstract][Full Text] [Related]
16. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure. Bowyer JF; Robinson B; Ali S; Schmued LC Synapse; 2008 Mar; 62(3):193-204. PubMed ID: 18081184 [TBL] [Abstract][Full Text] [Related]
17. Oxidative damage in substantia nigra and striatum of rats chronically exposed to ozone. Pereyra-Muñoz N; Rugerio-Vargas C; Angoa-Pérez M; Borgonio-Pérez G; Rivas-Arancibia S J Chem Neuroanat; 2006 Feb; 31(2):114-23. PubMed ID: 16236481 [TBL] [Abstract][Full Text] [Related]
18. Effects of homocysteine on the dopaminergic system and behavior in rodents. Lee ES; Chen H; Soliman KF; Charlton CG Neurotoxicology; 2005 Jun; 26(3):361-71. PubMed ID: 15935208 [TBL] [Abstract][Full Text] [Related]
19. Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats. Bowyer JF; Frame LT; Clausing P; Nagamoto-Combs K; Osterhout CA; Sterling CR; Tank AW J Pharmacol Exp Ther; 1998 Aug; 286(2):1074-85. PubMed ID: 9694971 [TBL] [Abstract][Full Text] [Related]
20. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. Pu C; Fisher JE; Cappon GD; Vorhees CV Brain Res; 1994 Jun; 649(1-2):217-24. PubMed ID: 7953636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]